We have shown that inhibition of PI3K signaling with a PI3Kα inhibitor (GDC-0032) decreased hyperpolarized 13C label exchange between injected [1-13C]pyruvate and the endogenous tumor lactate pool. Here, PIK3CB is linked to neoplasm.